CVR number 37741787
Industry 87.2010 Residential care activities for mental retardation, mental health and substance abuse

KVIK Bo-Selv ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.6% 1.6% 1.8% 1.5% 1.5%  
Credit score (0-100)  62 75 70 75 76  
Credit rating  BBB A A A A  
Credit limit (kDKK)  0.0 4.1 2.1 22.8 38.6  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales  0 0 0 0 0  
Gross profit  1,380 1,515 4,323 3,846 3,136  
EBITDA  608 565 1,751 2,286 1,874  
EBIT  512 402 1,578 2,074 1,544  
Pre-tax profit (PTP)  508.9 392.1 1,564.0 2,035.2 1,520.5  
Net earnings  377.7 304.3 1,245.0 1,549.9 1,183.6  
Pre-tax profit without non-rec. items  509 392 1,564 2,035 1,521  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Tangible assets total  584 541 807 1,417 1,665  
Shareholders equity total  721 1,026 2,214 3,707 4,831  
Interest-bearing liabilities  82.6 166 204 198 148  
Balance sheet total (assets)  970 1,433 3,181 4,557 5,530  
Net Debt  -243 -564 -1,897 -2,762 -3,521  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,380 1,515 4,323 3,846 3,136  
Gross profit growth  104.0% 9.8% 185.3% -11.0% -18.5%  
Employees  2 2 5 3 2  
Employee growth %  100.0% 0.0% 150.0% -40.0% -33.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  970 1,433 3,181 4,557 5,530  
Balance sheet change%  64.9% 47.8% 122.0% 43.2% 21.4%  
Added value  608.4 564.7 1,751.2 2,247.7 1,873.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  175 -205 92 398 -82  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  37.1% 26.6% 36.5% 53.9% 49.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  65.7% 33.5% 68.4% 53.6% 30.6%  
ROI %  81.4% 39.6% 86.0% 64.3% 34.1%  
ROE %  70.9% 34.8% 76.9% 52.4% 27.7%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  74.4% 71.6% 69.6% 81.3% 87.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -40.0% -100.0% -108.3% -120.8% -187.9%  
Gearing %  11.4% 16.2% 9.2% 5.3% 3.1%  
Net interest  0 0 0 0 0  
Financing costs %  3.2% 8.4% 7.3% 19.3% 13.6%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.7 2.3 2.6 4.1 6.4  
Current Ratio  1.7 2.3 2.6 4.1 6.4  
Cash and cash equivalent  325.6 730.3 2,101.0 2,960.1 3,669.5  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  156.8 503.9 1,445.9 2,378.8 3,258.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  304 282 350 749 937  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  304 282 350 762 937  
EBIT / employee  256 201 316 691 772  
Net earnings / employee  189 152 249 517 592